Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Dietary Supplements

MR. 7 SUPER 700000 Capsules Recalled for Undeclared Drug Ingredients

Agency Publication Date: March 5, 2026
Share:
Sign in to monitor this recall

Summary

StuffbyNainax is recalling 4 units of MR. 7 SUPER 700000 dietary supplement capsules because FDA laboratory analysis found the product contains undeclared sildenafil and tadalafil. Sildenafil and tadalafil are active ingredients in FDA-approved prescription drugs used to treat erectile dysfunction, but their presence in this product was not disclosed on the label. Consumers should stop using these capsules immediately and contact a healthcare provider if they have experienced any health problems related to this product.

Risk

The undeclared ingredients may interact with nitrates found in some prescription drugs (such as nitroglycerin) and could lower blood pressure to dangerous levels. This poses a significant risk to consumers with diabetes, high blood pressure, high cholesterol, or heart disease who often take nitrates.

What You Should Do

  1. Identify the product by checking for 'MR. 7 SUPER 700000' capsules on a 1-capsule blister card with an expiration date of 12/31/2029.
  2. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
  3. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: MR. 7 SUPER 700000 capsulesby MR. 7
Variants: 1 capsule blister card
Lot Numbers:
All codes (Exp 12/31/2029)

Distributed by mR. 7; Recall #: D-0397-2026

Product Images

Image of front label MR7 Super 700000 Dietary Supplement

Image of front label MR7 Super 700000 Dietary Supplement

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 98256
Status: Active
Manufacturer: StuffbyNainax
Sold By: mR. 7
Manufactured In: United States
Units Affected: 4
Distributed To: Nationwide
Agency Last Updated: March 18, 2026

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท FDA Press Release ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.